全文获取类型
收费全文 | 251345篇 |
免费 | 6930篇 |
国内免费 | 255篇 |
专业分类
耳鼻咽喉 | 2031篇 |
儿科学 | 8614篇 |
妇产科学 | 4060篇 |
基础医学 | 26866篇 |
口腔科学 | 2370篇 |
临床医学 | 20404篇 |
内科学 | 47190篇 |
皮肤病学 | 1531篇 |
神经病学 | 23899篇 |
特种医学 | 11815篇 |
外科学 | 41072篇 |
综合类 | 3187篇 |
一般理论 | 91篇 |
预防医学 | 23723篇 |
眼科学 | 4668篇 |
药学 | 14624篇 |
中国医学 | 716篇 |
肿瘤学 | 21669篇 |
出版年
2023年 | 668篇 |
2022年 | 1040篇 |
2021年 | 2414篇 |
2020年 | 1364篇 |
2019年 | 2217篇 |
2018年 | 24113篇 |
2017年 | 18859篇 |
2016年 | 21114篇 |
2015年 | 3079篇 |
2014年 | 3959篇 |
2013年 | 4768篇 |
2012年 | 13301篇 |
2011年 | 27358篇 |
2010年 | 22155篇 |
2009年 | 14571篇 |
2008年 | 24551篇 |
2007年 | 26945篇 |
2006年 | 5631篇 |
2005年 | 7202篇 |
2004年 | 7897篇 |
2003年 | 8482篇 |
2002年 | 6242篇 |
2001年 | 846篇 |
2000年 | 794篇 |
1999年 | 722篇 |
1998年 | 976篇 |
1997年 | 779篇 |
1996年 | 563篇 |
1995年 | 520篇 |
1994年 | 491篇 |
1993年 | 450篇 |
1992年 | 290篇 |
1991年 | 279篇 |
1990年 | 303篇 |
1989年 | 235篇 |
1988年 | 214篇 |
1987年 | 169篇 |
1986年 | 161篇 |
1985年 | 176篇 |
1984年 | 206篇 |
1983年 | 176篇 |
1982年 | 264篇 |
1981年 | 236篇 |
1980年 | 205篇 |
1979年 | 99篇 |
1978年 | 126篇 |
1977年 | 109篇 |
1976年 | 81篇 |
1974年 | 73篇 |
1938年 | 65篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
3.
Triposkiadis Filippos Xanthopoulos Andrew Skoularigis John Starling Randall C. 《Heart failure reviews》2022,27(6):1991-2003
Heart Failure Reviews - The nitric oxide (NO)–guanylate cyclase (GC)–cyclic guanosine monophosphate (cGMP) pathway plays an important role in cardiovascular, pulmonary and renal... 相似文献
4.
Seyed Mehdi BagheriMofidi Majid Pouladian Seyed Behnamedin Jameie Ali Abbaspour Tehrani-Fard 《Australasian physical & engineering sciences in medicine / supported by the Australasian College of Physical Scientists in Medicine and the Australasian Association of Physical Sciences in Medicine》2016,39(3):717-726
Magnetic field generated by neuronal activity could alter magnetic resonance imaging (MRI) signals but detection of such signal is under debate. Previous researches proposed that magnitude signal change is below current detectable level, but phase signal change (PSC) may be measurable with current MRI systems. Optimal imaging parameters like echo time, voxel size and external field direction, could increase the probability of detection of this small signal change. We simulate a voxel of cortical column to determine effect of such parameters on PSC signal. We extended a laminar network model for somatosensory cortex to find neuronal current in each segment of pyramidal neurons (PN). 60,000 PNs of simulated network were positioned randomly in a voxel. Biot–savart law applied to calculate neuronal magnetic field and additional phase. The procedure repeated for eleven neuronal arrangements in the voxel. PSC signal variation with the echo time and voxel size was assessed. The simulated results show that PSC signal increases with echo time, especially 100/80 ms after stimulus for gradient echo/spin echo sequence. It can be up to 0.1 mrad for echo time = 175 ms and voxel size = 1.48 × 1.48 × 2.18 mm3. With echo time less than 25 ms after stimulus, it was just acquired effects of physiological noise on PSC signal. The absolute value of the signal increased with decrease of voxel size, but its components had complex variation. External field orthogonal to local surface of cortex maximizes the signal. Expected PSC signal for tactile detection in the somatosensory cortex increase with echo time and have no oscillation. 相似文献
5.
6.
7.
8.
Xin Yi Wong Andrew Qi Jun Lim Qianyu Shen John Whay Kuang Chia Min Hoe Chew Wah Siew Tan 《Current medical research and opinion》2020,36(10):1677-1686
Abstract
Objective
Ras wild-type metastatic colorectal cancers (mCRC) may be treated with anti-vascular endothelial growth factor (VEGF) or anti-epidermal growth factor receptor (EGFR) agents. We aim to estimate patients’ preferences for mCRC treatment and relative importance of cost, efficacy improvement, avoidance of side effects and therapy convenience, and relative uptake between profiles that resemble Bevacizumab (anti-VEGF) and Cetuximab (anti-EGFR), two commonly prescribed mCRC targeted therapies. 相似文献9.